[144] The Vita Coco Company, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filing highlights
On 18 June 2025, an affiliate of The Vita Coco Company, Inc. (NASDAQ: COCO) filed a Form 144 with the U.S. SEC. The notice states the filer intends to sell 10,000 common shares through Morgan Stanley Smith Barney LLC at an aggregate market value of $345,900, implying a reference price near $34.59 per share. The shares were acquired the same day via the exercise of stock options and are scheduled for sale on or about 18 June 2025 on the NASDAQ.

Transaction scale
The planned disposition equals roughly 0.018 % of Vita Coco’s 56,733,572 shares outstanding, signalling a de-minimis impact on the company’s float and no dilution, as the shares are already issued. The filer reported no other sales during the prior three-month period.

Regulatory context
Form 144 is a routine notice required when company insiders or affiliates intend to sell restricted or control securities under Rule 144. By signing, the filer affirms that no non-public material adverse information is known. No additional financial or operational data were provided in the document.

Positive

• None.

Negative

• Form 144 reveals an insider plans to sell 10,000 shares, indicating a reduction in insider ownership.

Insights

Securities Analyst

TL;DR: Small insider sale (10k shares, $345k) — immaterial to COCO’s capital structure; neutral signal.

From a capital-markets perspective, the proposed sale is negligible at 0.018 % of outstanding shares and does not introduce dilution. While insider sales can occasionally be interpreted as negative sentiment, the size and the option-exercise origin suggest routine liquidity management. No other insider sales in the past 90 days further reduces concern. Overall, I view the filing as informational rather than impactful.

Corporate Governance Expert

TL;DR: Routine Rule 144 disclosure; governance processes appear followed, no red flags.

The notice demonstrates compliance with SEC Rule 144 timing and disclosure requirements. The signer explicitly represents the absence of undisclosed adverse information, and the broker is a reputable firm. Lack of prior-quarter sales indicates adherence to aggregation limits. Because the individual’s identity and relationship to the issuer are not disclosed in the excerpt, investors cannot assess ownership changes in detail, but the transaction size alone does not raise governance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	345900.00	56733572	06/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/18/2025	Exercise of Stock Options	Issuer			10000	06/18/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Vita Coco's (COCO) Form 144 filing disclose?

It disclosed a planned sale of 10,000 common shares worth $345,900 by an affiliate on 18 June 2025.

How large is the planned share sale relative to COCO's shares outstanding?

The 10,000 shares equal about 0.018 % of the 56,733,572 shares outstanding.

What is the approximate sale date mentioned in the filing?

The filing lists 18 June 2025 as the approximate sale date.

Which broker is handling the sale of Vita Coco shares?

The broker named is Morgan Stanley Smith Barney LLC.

How were the shares to be sold acquired?

They were acquired through the exercise of stock options on 18 June 2025, paid in cash.